1.Correlation between peripheral blood mitochondrial DNA and urine microalbumin in patients with type 2 diabetes mellitus
Da CHEN ; Juli ZENG ; Chenxia ZHOU ; Ziyi LI ; Bo FENG ; Jun SONG
Chinese Journal of Diabetes 2025;33(4):248-251
Objective To explore the relationship between peripheral blood mitochondrial DNA(mtDNA)copy number and urinary microalbumin(MAlb)in patients with type 2 diabetes mellitus(T2DM).Methods 87 patients with T2DM from the Endocrinology Department of East Hospital of Tongji University were selected based on inclusion criteria.According to urinary MAlb levels,patients were divided into T2DM group(MAlb<30 mg/L)and MAlb group(MAlb>30 mg/L).General patient information was collected,and clinical indicators such as blood glucose,lipid profile,glycated hemoglobin and insulin were measured.Peripheral blood mtDNA was extracted and the copy number was detected using real-time quantitative polymerase chain reaction(RT-PCR).Logistic regression analysis was used to identify the risk factors for albuminuria.Results Compared with T2DM group,DM duration,serum creatinine,serum uric acid and copy number of mtDNA in MAlb group increased(P<0.05),while high density lipoprotein cholesterol decreased(P<0.05).Logistic analysis showed that the copy number of mtDNA was the influencing factor of MAlb in T2DM patients.Conclusions The peripheral blood mtDNA copy number in T2DM patients is positively correlated with urinary microalbumin,thus providing a potential target for early detection of DKD.
2.Correlation between peripheral blood mitochondrial DNA and urine microalbumin in patients with type 2 diabetes mellitus
Da CHEN ; Juli ZENG ; Chenxia ZHOU ; Ziyi LI ; Bo FENG ; Jun SONG
Chinese Journal of Diabetes 2025;33(4):248-251
Objective To explore the relationship between peripheral blood mitochondrial DNA(mtDNA)copy number and urinary microalbumin(MAlb)in patients with type 2 diabetes mellitus(T2DM).Methods 87 patients with T2DM from the Endocrinology Department of East Hospital of Tongji University were selected based on inclusion criteria.According to urinary MAlb levels,patients were divided into T2DM group(MAlb<30 mg/L)and MAlb group(MAlb>30 mg/L).General patient information was collected,and clinical indicators such as blood glucose,lipid profile,glycated hemoglobin and insulin were measured.Peripheral blood mtDNA was extracted and the copy number was detected using real-time quantitative polymerase chain reaction(RT-PCR).Logistic regression analysis was used to identify the risk factors for albuminuria.Results Compared with T2DM group,DM duration,serum creatinine,serum uric acid and copy number of mtDNA in MAlb group increased(P<0.05),while high density lipoprotein cholesterol decreased(P<0.05).Logistic analysis showed that the copy number of mtDNA was the influencing factor of MAlb in T2DM patients.Conclusions The peripheral blood mtDNA copy number in T2DM patients is positively correlated with urinary microalbumin,thus providing a potential target for early detection of DKD.
3.Study of No Observed Adverse Effect Level of Nickel and Its Preliminary Evaluation Biocompatibility.
Xueying HE ; Juli TANG ; Xiantao WEN ; Bo GUAN ; Rui WANG ; Hui WANG ; Hua LI ; Jianfeng SHI ; Yali ZENG ; Yongjian MAO
Chinese Journal of Medical Instrumentation 2020;44(5):448-452
The purpose of this study was to investigate the NOAEL of the nickel ion and provide with basic data for the biological evaluation of those medical devices containing nickel. Five groups SD rats were repeatedly exposed during 14 d respectively to nickel at first stage doses of 4.9, 3.7, 2.5 mg/(kg.d), and the second stage doses of 1.2, 0.25 mg/(kg.d) by the intravenous route. The results showed that the NOAEL of nickel ion is 0.25 mg/(kg.d) for SD rats, and the result was verified by subchronic systemic toxicity test of nickel alloy. The threshold of toxicological concern (TTC) of nickel is 150 μg/d (based on application of 100-fold uncertainty factor and a body weight of 60 kg)deduced by these data.
Animals
;
Equipment and Supplies/adverse effects*
;
Nickel/toxicity*
;
No-Observed-Adverse-Effect Level
;
Rats
;
Rats, Sprague-Dawley
;
Risk Assessment

Result Analysis
Print
Save
E-mail